Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recombinant human hyaluronidase-facilitated subcutaneous infusion pharmacodynamics study in Chinese healthy adults
ChiCTR2100049727Phase 3Not yet recruiting
- Sponsor
- Changhai Hospital
- Start
- Jan 2021
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label trial of hyaluronidase (3 arms), sponsored by Changhai Hospital. Primary endpoints: Rate of subcutaneous infusion, Arm circumference and 2 more. Planned start Jan 2021; status: not yet recruiting.
02
Drugs
hyaluronidase
Beyond the preview
Go deeper on ChiCTR2100049727.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100049727.